HIV maturation inhibitor

Ph. II candidate for HIV

from prior clinical candidate

Antimicrob. Agents Chemother.

ViiV Healthcare (GSK)

HIV maturation inhibitor - ViiV Healthcare (GSK)

GSK3640254 is an HIV maturation inhibitor and Ph. IIb clinical candidate (60-180 mg PO QD) with activity against a range of HIV strains with Gag polymorphisms. The first HIV…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: